BOLT: Bolt Biotherapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 11.89
Enterprise Value ($M) 3.49
Book Value ($M) 46.81
Book Value / Share 1.22
Price / Book 0.25
NCAV ($M) 3.46
NCAV / Share 0.09
Price / NCAV 3.44

Profitability (mra)
Return on Invested Capital (ROIC) -0.89
Return on Assets (ROA) -0.44
Return on Equity (ROE) -0.61

Liquidity (mrq)
Quick Ratio 3.13
Current Ratio 3.13

Balance Sheet (mrq) ($M)
Current Assets 42.51
Assets 85.86
Liabilities 39.05
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 7.69
Operating Income -68.24
Net Income -63.12

Cash Flow Statement (mra) ($M)
Cash From Operations -61.29
Cash from Investing 57.58
Cash from Financing 0.11

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
7 days ago 13G/A Tang Capital Management Llc 9.90
11-14 13G/A Citadel Advisors Llc 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-24 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-21 3,678,833 10,328,644 35.62
2025-05-20 21,358 114,169 18.71
2025-05-19 106,214 257,287 41.28
2025-05-16 24,489 123,171 19.88

(click for more detail)

Similar Companies
BIVI – BioVie Inc. BMRA – Biomerica, Inc.
BNTC – Benitec Biopharma Inc. BON – Bon Natural Life Limited
BTAI – BioXcel Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io